| Market Cap | ₹71,134Cr |
| ROE | 9.77% |
| P/E Ratio(TTM) | 20.79 |
| EPS(TTM) | 58.90 |
| P/B Ratio | 2.03 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.07 |
| Book Value | 603.32 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Parent Organisation | Aurobindo Pharma Limited |
| Managing Director | K. Nithyananda Reddy |
| Founded | 1986 |
| NSE Symbol | AUROPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.93 | ||
| Cipla | NA (0.00%) | 22.55 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.60 | ||
| Lupin | NA (0.00%) | 22.34 |